Dossier
Interception program
Coverage of Interception program in the Nexus archive.
- Pancreatic cancer: Dr. Pudlarz praises 'new generation targeted therapy' that inhibits gene mutation
Dr. Thomas Pudlarz, a Medical Oncologist at the Gustave-Roussy Institute, highlights a new experimental targeted therapy for pancreatic cancer as a significant advancement. Pancreatic cancer remains a major challenge in oncology, but this therapy represents one of the first improvements in many years.